http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200922607-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aae9861b012f72ac2b618cde29d790a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b3fc610de9fd916ce5fcb698405fe27 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-72 |
| filingDate | 2007-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f65288684d1486ce2f372935db6cabd4 |
| publicationDate | 2009-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-200922607-A |
| titleOfInvention | Pharmaceutical composition used to treat the anxiety disorder |
| abstract | The present invention discloses a pharmaceutical composition(or health care food) which utilizes the Ginsenoside(Rg1+Rb1), the Glycyrrhizic acid and the Jujuba cAMP as the material, and is used to treat the anxiety disorder. Especially, this pharmaceutical composition (or health care food) has the confirmed effective components, theobvious therapy effect, lower side effect, and long-term safety. Compared to the Diazepam which is a main drug to treat the anxiety disorder in the prior art, the experiment shows that the pharmaceutical composition of this invention has an obvious therapy effect to treat the anxiety disorder. |
| priorityDate | 2007-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.